# Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery

> **NCT00538590** · PHASE4 · COMPLETED · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 20 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **DEVICE:** Collagen Matrix in Glaucoma Filtering Surgery
- **DRUG:** Mitomycin-C(MMC) and glaucoma filtering surgery

## Key facts

- **NCT ID:** NCT00538590
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538590, "Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00538590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*